Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02659384
Brief Title: Anti-programmed Cell Death-1 Ligand 1 (aPDL-1) Antibody Atezolizumab, Bevacizumab and Acetylsalicylic Acid in Recurrent Platinum Resistant Ovarian Cancer

First Submitted : January 14, 2016
First Submitted that Met QC Criteria : January 15, 2016
First Posted : January 20, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : July 30, 2020
Last Update Posted : July 31, 2020